Daniel F Marker

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. pmc LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein
    Daniel F Marker
    Center for Neural Development and Disease, Department of Neurology, Child Neurology Division, University of Rochester, Rochester, NY, USA
    J Neuroinflammation 9:261. 2012
  2. pmc The new small-molecule mixed-lineage kinase 3 inhibitor URMC-099 is neuroprotective and anti-inflammatory in models of human immunodeficiency virus-associated neurocognitive disorders
    Daniel F Marker
    Centers for Neural Development and Disease, University of Rochester, Rochester, New York 14642, USA
    J Neurosci 33:9998-10010. 2013
  3. pmc HIV-1 Tat-induced microgliosis and synaptic damage via interactions between peripheral and central myeloid cells
    Shao Ming Lu
    Center for Neural Development and Disease, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America
    PLoS ONE 6:e23915. 2011

Detail Information

Publications3

  1. pmc LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein
    Daniel F Marker
    Center for Neural Development and Disease, Department of Neurology, Child Neurology Division, University of Rochester, Rochester, NY, USA
    J Neuroinflammation 9:261. 2012
    ....
  2. pmc The new small-molecule mixed-lineage kinase 3 inhibitor URMC-099 is neuroprotective and anti-inflammatory in models of human immunodeficiency virus-associated neurocognitive disorders
    Daniel F Marker
    Centers for Neural Development and Disease, University of Rochester, Rochester, New York 14642, USA
    J Neurosci 33:9998-10010. 2013
    ..In conclusion, these data provide compelling in vitro and in vivo evidence to investigate the utility of URMC-099 in other models of HAND with the goal of advancement to an adjunctive therapeutic agent...
  3. pmc HIV-1 Tat-induced microgliosis and synaptic damage via interactions between peripheral and central myeloid cells
    Shao Ming Lu
    Center for Neural Development and Disease, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America
    PLoS ONE 6:e23915. 2011
    ....